Cordycepin enhances the chemosensitivity of esophageal cancer cells to cisplatin by inducing the activation of AMPK and suppressing the AKT signaling pathway

Although cisplatin (cDDP), is a first-line chemotherapy drug for esophageal cancer, it still has the potential to develop drug resistance and side effects. There is increasing evidence that cordycepin can work synergistically with other chemotherapy drugs. Therefore, we investigated whether combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ying, Chen, Dan-Lei, Zhou, Mi, Zheng, Zhou-san, He, Mei-Fang, Huang, Sheng, Liao, Xiao-Zhong, Zhang, Jia-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567864/
https://www.ncbi.nlm.nih.gov/pubmed/33067427
http://dx.doi.org/10.1038/s41419-020-03079-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567864/
https://www.ncbi.nlm.nih.gov/pubmed/33067427
http://dx.doi.org/10.1038/s41419-020-03079-4

Ejemplares similares